Impaired expression of duodenal iron transporters in Dahl salt-sensitive heart failure rats

Journal of Hypertension

Volumn 29, Issue 4, 2011, Pages 741-748

  Naito, Yoshiro ^a   Tsujino, Takeshi ^a   Fujimori, Yoshihiro ^b   Sawada, Hisashi ^a   Akahori, Hirokuni ^a   Hirotani, Shinichi ^a   Ohyanagi, Mitsumasa ^a   Masuyama, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Cancer Center   (Japan)

Author keywords

anemia; dahl salt sensitive rats; divalent metal transporter 1; heart failure; hypoxia inducible factor 2a; iron

Indexed keywords

CYTOCHROME B; ERYTHROPOIETIN; FERROPORTIN; HEPCIDIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; DOWN REGULATION; DUODENUM; HEART FAILURE; HYPERTENSION; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON TRANSPORT; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SALT INTAKE; UPREGULATION;

EID: 79952761370     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283434784     Document Type: Article

References (28)

1. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39:1780-1786. (Pubitemid 34595288)
2. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008; 52:818-827.
3. Felker GM, Shaw LK, Stough WG, O'Connor CM. Anemia in patients with heart failure and preserved systolic function. Am Heart J 2006; 151:457-462. (Pubitemid 43144750)
4. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al., CHARM Committees and Investigators. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in heart failure - Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006; 113:986-994. (Pubitemid 43879474)
5. Okonko DO, Anker SD. Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail 2004; 10:S5-S9. (Pubitemid 38879389)
6. Anand IS. Anemia and chronic heart failure: implications and treatment options. J Am Coll Cardiol 2008; 52:501-511.
7. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006; 48:2485-2489. (Pubitemid 44881220)
8. Adlbrecht C, Kommata S, Hülsmann M, Szekeres T, Bieglmayer C, Strunk G, et al. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J 2008; 29:2343-2350.
9. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005; 1:191-200. (Pubitemid 43960600)
10. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-2093. (Pubitemid 40007660)
11. Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. Intestinal hypoxiainducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 2009; 9:152-164.
12. MastrogiannakiM, Matak P, Keith B, Simon MC, Vaulont S, Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 2009; 119:1159-1166.
13. Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T. Adaptive response of the heart to long term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 2009; 296:H585-H593.
14. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113:1271-1276. (Pubitemid 39069926)
15. O'Tierney PF, Komolova M, Tse MY, Adams MA, Pang SC. Altered regulation of renal interstitial hydrostatic pressure and the renal reninangiotensin system in the absence of atrial natriuretic peptide. J Hypertens 2008; 26:303-311.
16. Masuyama T, Yamamoto K, Sakata Y, Doi R, Nishikawa N, Kondo H, et al. Evolving changes in Doppler mitral flow velocity pattern in rats with hypertensive hypertrophy. J Am Coll Cardiol 2000; 36:2333-2338.
17. Naito Y, Tsujino T, Kawasaki D, Okumura T, Morimoto S, Masai M, et al. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar- Kyoto rats. J Hypertens 2003; 21:1107-1115. (Pubitemid 36667864)
18. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Iwasaki T. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension 2002; 40:827-833. (Pubitemid 35434902)
19. Naito Y, Tsujino T, Akahori H, Ohyanagi M, Mitsuno M, Miyamoto Y, et al. Increase in tissue and circulating pentraxin3 levels in patients with aortic valve stenosis. Am Heart J 2010; 160:685-691.
20. Fujimori Y, Ogawa M, Clark SC, Dover GJ. Serum-free culture of enriched hematopoietic progenitors reflects physiologic levels of fetal hemoglobin biosynthesis. Blood 1990; 75:1718-1722. (Pubitemid 20145762)
21. Johnson D, Bayele H, Johnston K, Tennant J, Srai SK, Sharp P. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett 2004; 573:195-201. (Pubitemid 39141057)
22. Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxiainducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 1996; 271:32253-32259. (Pubitemid 26422262)
23. Chen H, Shi H. A reducing environment stabilizes HIF-2alpha in SH-SY5Y cells under hypoxic conditions. FEBS Lett 2008; 582:3899-3902.
24. de Silva R, Rigby AS, Witte KK, Nikitin NP, Tin L, Goode K, et al. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol 2006; 98:391-398. (Pubitemid 44062453)
25. Klotz S, Hay I, Zhang G, Maurer M, Wang J, Burkhoff D. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension 2006; 47:901-911. (Pubitemid 44297562)
26. Knutson MD. Iron-sensing proteins that regulate hepcidin and enteric iron absorption. Annu Rev Nutr 2010; 30:149-171.
27. Huang H, Constante M, Layoun A, Santos MM. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009; 113:3593-3599.
28. Simchon S, Manger WM, Brown TW. Dual hemodynamic mechanisms for salt-induced hypertension in Dahl salt-sensitive rats. Hypertension 1991; 17:1063-1071.